Autolus Therapeutics PLC (AUTL)
4.515
-0.06
(-1.20%)
USD |
NASDAQ |
Apr 23, 16:00
4.515
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Total Assets (Quarterly): 375.38M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 375.38M |
| September 30, 2023 | 406.10M |
| June 30, 2023 | 450.99M |
| March 31, 2023 | 459.97M |
| December 31, 2022 | 490.27M |
| September 30, 2022 | 263.83M |
| June 30, 2022 | 313.98M |
| March 31, 2022 | 363.99M |
| December 31, 2021 | 405.56M |
| September 30, 2021 | 296.64M |
| June 30, 2021 | 330.66M |
| Date | Value |
|---|---|
| March 31, 2021 | 349.75M |
| December 31, 2020 | 294.24M |
| September 30, 2020 | 317.08M |
| June 30, 2020 | 310.55M |
| March 31, 2020 | 337.66M |
| December 31, 2019 | 303.53M |
| September 30, 2019 | 314.64M |
| June 30, 2019 | 346.14M |
| March 31, 2019 | 264.36M |
| March 31, 2018 | 143.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
263.83M
Minimum
Sep 2022
490.27M
Maximum
Dec 2022
354.26M
Average
337.66M
Median
Mar 2020
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 282.62M |
| Biodexa Pharmaceuticals Plc | 13.43M |
| NuCana PLC | 35.43M |
| TC BioPharm (Holdings) PLC | 11.38M |
| Mereo BioPharma Group PLC | 66.50M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 263.91M |
| Shareholders Equity (Quarterly) | 111.47M |